3-iodo-7-(8-iodo-10-phenyl-5,10-dihydro-phenazin-2-ylamino)-5-phenyl-phenazin-5-ium

ID: ALA203722

Chembl Id: CHEMBL203722

PubChem CID: 3246691

Max Phase: Preclinical

Molecular Formula: C36H24I2N5+

Molecular Weight: 780.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Ic1ccc2c(c1)N(c1ccccc1)c1cc(Nc3ccc4nc5ccc(I)cc5[n+](-c5ccccc5)c4c3)ccc1N2

Standard InChI:  InChI=1S/C36H23I2N5/c37-23-11-15-29-33(19-23)42(27-7-3-1-4-8-27)35-21-25(13-17-31(35)40-29)39-26-14-18-32-36(22-26)43(28-9-5-2-6-10-28)34-20-24(38)12-16-30(34)41-32/h1-22H,(H,40,41)/p+1

Standard InChI Key:  DRLPKIYKZSQYRJ-UHFFFAOYSA-O

Associated Targets(Human)

PPM1A Tchem Protein phosphatase 2C alpha (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALDH1A1 Tchem Aldehyde dehydrogenase 1A1 (77053 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GNB1 Tbio Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1/gamma-2 (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cruzipain (33337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 780.43Molecular Weight (Monoisotopic): 780.0116AlogP: 10.14#Rotatable Bonds: 4
Polar Surface Area: 44.07Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 0.97CX LogP: 7.53CX LogD: 7.53
Aromatic Rings: 7Heavy Atoms: 43QED Weighted: 0.11Np Likeness Score: -0.84

References

1. Rogers JP, Beuscher AE, Flajolet M, McAvoy T, Nairn AC, Olson AJ, Greengard P..  (2006)  Discovery of protein phosphatase 2C inhibitors by virtual screening.,  49  (5): [PMID:16509582] [10.1021/jm051033y]
2. PubChem BioAssay data set, 
3. PubChem BioAssay data set, 
4.  (2010)  Compositions and methods for inhibiting g protein signaling,